In androgen-sensitive LNCaP prostate cancer cells, immunoprecipitation of endogenous AR after DHT treatment or Ack1 expression demonstrated that association between AR and SLIRP is inhibited by DHT or Ack1 activation (Fig. 1C). The gene discussed is TNK2; the disease is Familial prostate cancer.